Importantly, PP2A and GSK3 pharmacological inhibition in human cells rescued hallmark ALS-associated phenotypes, including FUS cytoplasmic mislocalization, NMJ formation, and mitochondrial transport defects. The gene discussed is PTPA; the disease is amyotrophic lateral sclerosis.